ImmuPharma plc (AIM:IMM)
London · Delayed Price · Currency is GBP · Price in GBX 3.600
+0.140 (4.05%)
Sep 4, 2026, 4:35 PM GMT
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 22.46 million as of September 4, 2026. Its market cap has decreased by -15.99% in one year.
Market Cap
22.46M
Enterprise Value
21.11M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.60
ChartMarket Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 22.46M, a decrease of -37.80%. That is a compound annual growth rate of -2.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 22.46M | -27.94% |
| Dec 31, 2025 | 31.17M | 521.13% |
| Dec 31, 2024 | 5.02M | -27.71% |
| Dec 29, 2023 | 6.94M | 13.16% |
| Dec 30, 2022 | 6.13M | -62.85% |
| Dec 31, 2021 | 16.51M | -50.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sareum Holdings | 48.50M |
| hVIVO | 46.72M |
| Hemogenyx Pharmaceuticals | 38.42M |
| Arecor Therapeutics | 27.94M |
| SkinBioTherapeutics | 24.62M |
| IXICO | 16.35M |
| Fusion Antibodies | 15.33M |
| Palatin Technologies | 15.01M |